Posaconazole Plasma Monitoring in Immunocompromised Children.
J Pediatric Infect Dis Soc
; 6(4): 389-392, 2017 Nov 24.
Article
em En
| MEDLINE
| ID: mdl-28186550
ABSTRACT
Plasma posaconazole exposure was assessed in 13 children who underwent a hematopoietic stem cell transplant. The median dosage was 12.5 mg/kg per day, divided into 3 doses. Of these 13 patients, 46.2% (6) and 30.8% (4) achieved concentrations higher than 0.7 and 1.25 mg/L, respectively. In children at high risk, a higher dosage might be needed to achieve target concentrations.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Triazóis
/
Hospedeiro Imunocomprometido
/
Transplante de Células-Tronco Hematopoéticas
Tipo de estudo:
Observational_studies
/
Risk_factors_studies
Limite:
Child
/
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
Idioma:
En
Revista:
J Pediatric Infect Dis Soc
Ano de publicação:
2017
Tipo de documento:
Article